Sowell Financial Services’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Sowell Financial Services’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-300	Closed	–	–	2836
2019 Q4	$0	Hold	300	–	–	﹤0.01%	2740
2019 Q3	$1K	Buy	+300	New	+$1.08K	﹤0.01%	2370

Sowell Financial Services's MLNT Position: Q1 2020 in Review

Sowell Financial Services sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q1 2020, closing a stake of 300 shares.

Sowell Financial Services first reported a position in MLNT in Q3 2019 and held it in 2 quarters. The position peaked at $1K in Q3 2019. 2 funds tracked by Wall St. Rank hold MLNT as of Q1 2020.

Sowell Financial Services reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
Sowell Financial Services sold 300 Melinta Therapeutics, Inc. Common Stock shares in Q1 2020.
Sowell Financial Services first reported a position in Melinta Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
Sowell Financial Services's Melinta Therapeutics, Inc. Common Stock position peaked at $1K in Q3 2019.
2 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q1 2020.

Based on Sowell Financial Services's 13F filing for Q1 2020, filed 12 May 2020.